Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?

Loukman Omarjee; Olivier Meilhac; Frédérique Perrot; Anne Janin; Guillaume Mahe

doi:10.1016/j.clim.2020.108468

Journal articles

Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?

Loukman Omarjee ^{1, 2, *} Olivier Meilhac ^{3, 4} Frédérique Perrot ⁵ Anne Janin ⁶ Guillaume Mahe ^{7, 1}

* Corresponding author

1 CIC - Centre d'Investigation Clinique [Rennes]

2 NuMeCan - Nutrition, Métabolismes et Cancer

3 DéTROI - Diabète athérothrombose et thérapies Réunion Océan Indien

4 CHU La Réunion - Centre Hospitalier Universitaire de La Réunion

5 Chercheur indépendant

6 MASCOT (UMR_S_942 / U942) - Marqueurs cardiovasculaires en situation de stress

7 CHU Pontchaillou [Rennes]

Keywords : COVID-19 Neutrophil extracellular traps P2Y12 inhibitor Ticagrelor Platelets – Neutrophils aggregates Sepsis-induced coagulopathy Vascular leakage

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Life Sciences [q-bio] / Immunology

Complete list of metadata

Cited literature [21 references] Display Hide Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02859926
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Tuesday, June 16, 2020 - 10:18:43 AM
Last modification on : Monday, January 10, 2022 - 9:49:36 AM

Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?

File

Identifiers

Collections

Citation

Export

Metrics

Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?

File

Identifiers

Collections

Citation

Export

Share

Metrics